Simon Glerup

Company: Draupnir Bio Aps

Job title: Chief Scientific Officer

Seminars:

Harnessing Lysosomal Pathways for Effective Targeted Protein Degradation of Novel Targets to Cure Untreated Diseases 11:00 am

Validating the lysosomal degradation pathway to define its targetable space, similar to the ubiquitination pathway in intracellular degradation Designing warheads to engage lysosomal sorting receptors to select novel proteins for degradation and pharmacological benefit Expanding the application of lysosomal degradation to different types of extracellular proteins in complex systems and organs to enable tissue specificityRead more

day: Day 2, Track 2, AM

PANEL DISCUSSION Clear Skies or Stormy Seas: Sailing the European Markets in Search of Funding & Partnerships for Effective Degrader Development 8:45 am

What are the trends in the current European investment environment, and how can emerging companies effectively demonstrate commercial viability in these conditions? What is the average European life sciences VC’s risk appetite, and how can biotechs navigate this to secure investment? How do the dynamics of biotech-to-biotech deals compare to pharma partnerships? Does Europe need…Read more

day: Day Two Until 10am